Aldeyra Therapeutics, Inc. (ALDX) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
ALDX currently has 60.3M outstanding shares. with limited dilution risk as only 3.34M additional shares (5.5%) are authorized for issuance. The company has minimally diluted shareholders by 1.59% over the past 2 years.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| May 07, 2026 |
10-Q filing | 60.3M shares outstanding |
60M | 3.3M |
| Nov 05, 2025 |
10-Q filing | 60.1M shares outstanding |
60M | 3.5M |
| Aug 07, 2025 |
10-Q filing | 60.0M shares outstanding |
60M | 3.6M |
| May 14, 2025 |
10-Q filing | 59.9M shares outstanding |
60M | 3.8M |
| Feb 28, 2025 |
10-K filing | 59.5M shares outstanding |
59M | 4.2M |
| Nov 07, 2024 |
10-Q filing | 59.5M shares outstanding |
60M | 4.1M |
| Aug 01, 2024 |
10-Q filing | 59.4M shares outstanding |
59M | 4.2M |
| May 02, 2024 |
10-Q filing | 59.4M shares outstanding |
59M | 4.2M |
| Mar 07, 2024 |
S-3 filing: The company may offer and sell up to $200 million in common stock and preferred stock from time to time in one or more offerings. |
59M | 4.7M |
| Mar 07, 2024 |
10-K filing | 58.9M shares outstanding |
59M | 4.7M |
| Nov 03, 2023 |
10-Q filing | 59.0M shares outstanding |
59M | 4.7M |
| Aug 03, 2023 |
10-Q filing | 58.8M shares outstanding |
59M | 4.9M |
| May 04, 2023 |
10-Q filing | 58.8M shares outstanding |
59M | 4.9M |
| Mar 09, 2023 |
10-K filing | 58.4M shares outstanding |
58M | 5.2M |
| Nov 10, 2022 |
10-Q filing | 58.5M shares outstanding |
58M | 5.2M |
| Aug 05, 2022 |
10-Q filing | 58.3M shares outstanding |
58M | 5.4M |
| May 05, 2022 |
10-Q filing | 58.3M shares outstanding |
58M | 5.4M |
| Mar 17, 2022 |
10-K filing | 58.1M shares outstanding |
58M | 5.6M |
| Oct 28, 2021 |
10-Q filing | 58.1M shares outstanding |
58M | 5.6M |
| Aug 05, 2021 |
10-Q filing | 57.9M shares outstanding |
58M | 5.8M |
| May 06, 2021 |
10-Q filing | 57.6M shares outstanding |
58M | 6M |
| Mar 11, 2021 |
S-3 filing: The company is filing an S-3 to offer and sell up to $300 million in common stock and preferred stock. |
39M | 25M |
| Mar 11, 2021 |
10-K filing | 47.2M shares outstanding |
47M | 16M |
| Nov 05, 2020 |
10-Q filing | 38.8M shares outstanding |
39M | 0 |
| Aug 06, 2020 |
10-Q filing | 38.6M shares outstanding |
39M | 0 |
| May 07, 2020 |
10-Q filing | 29.8M shares outstanding |
30M | 0 |
| Mar 12, 2020 |
10-K filing | 29.7M shares outstanding |
30M | 0 |